Patent EP0170247A2 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0170247A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Hemoglobin-containing liposomes and process for preparing the same

Assignee: Terumo Corp
•
Filing: 1985-07-29
•
Granted: —
•
Expires: 2005-07-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 57 There are provided hemoglobin-containing liposomes encapsulating within liposomes having membranes comprising a lipid material hemoglobin and a methemoglobin formation-inhibiting agent. The liposomes are used as artificial blood with high oxygen-carrying capacity. As the lipid material of the liposomes are used phospholipid materials such as, for example, lecithin, phosphatidylethanolamine, phosphatidic acid, sphingomyelin and hydrogenation products thereof. As the methemoglobin formation-inhibiting agent are used salts of ascorbic acid, glutathion and the like. The liposomes are prepared by dissolving a liposome membrane-forming lipid material and a surface-active agent, removing the solvent from said solution, adding to the residue a hemoglobin solution to which a methemoglobin formation-inhibiting agent has beer added and subjecting the starting solution thus obtained to dialysis with a physiological saline solution containing the same methemoglobin formation-inhibiting agent to remove the surface-active agent from the starting solution.

Inventors

  • 👤 Kazuhiko Suzuki
  • 👤 Yuji Miyauchi

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-09 22:29
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/10; A61K9/127; A61K9/1277; A61K38/00; A61K38/16; A61K38/41; A61K38/42; A61P; A61P7/00; A61P7/08

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 18 words
Hemoglobin-containing liposomes which have membranes comprising a lipid material and encapsulate hemoglobin and a methemoglobin formation-inhibiting agent therein.
Claim 2
Dependent Claim 18 words
Hemoglobin-containing liposomes which have membranes comprising a lipid material and encapsulate hemoglobin and a methemoglobin formation-inhibiting agent therein.
Claim 3
Dependent Claim 29 words
Liposomes according to Claim 1 wherein the lipid material is a phospholipid material selected from lecithin, phosphatidylethanolamine, phosphatidic acid, phosphatidyl- serin, phosphatidylinositol, phosphatidylglycerol, sphingomyelin, cardiolipin and hydrogenation products thereof.
Claim 4
Dependent Claim 20 words
Liposomes according to Claim 1 or 2 wherein the methemoglobin formation-inhibiting agent is a salt of ascorbic acid or glutathion.
Claim 5
Dependent Claim 49 words
Liposomes according to Claims 1 - 3 wherein concentration of the hemoglobin contained in the liposomes is in the range from 5 to 45% (w/w) and an amount of the methemoglobin formation-inhibiting agent used is in the range from 2 to 10 times the molar amount of the hemoglobin.
Claim 6
Dependent Claim 93 words
Process for preparing hemoglobin-containing liposomes which comprises dissolving a liposome membrane-forming lipid material and a surface-active agent in an organic solvent, removing the solvent from said solution, adding to the residue a physiological saline solution of hemoglobin to which a methemoglobin formation-inhibiting agent has been added and subjecting the starting solution thus obtained to dialysis with a physiological saline solution containing the same methemoglobin formation-inhibiting agent to remove the surface-active agent from the starting solution, thereby encapsulating the hemoglobin and the methemoglobin formation-inhibiting agent in the liposomes with membranes comprising the lipid material.
Claim 7
Dependent Claim 93 words
Process for preparing hemoglobin-containing liposomes which comprises dissolving a liposome membrane-forming lipid material and a surface-active agent in an organic solvent, removing the solvent from said solution, adding to the residue a physiological saline solution of hemoglobin to which a methemoglobin formation-inhibiting agent has been added and subjecting the starting solution thus obtained to dialysis with a physiological saline solution containing the same methemoglobin formation-inhibiting agent to remove the surface-active agent from the starting solution, thereby encapsulating the hemoglobin and the methemoglobin formation-inhibiting agent in the liposomes with membranes comprising the lipid material.
Claim 8
Dependent Claim 18 words
Process for preparing liposomes according to Claim 5 wherein the surface-active agent is a salt of cholic acid.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag